Mast Cells in Lung Inflammation

  • Elena P. Moiseeva
  • Peter Bradding
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 716)


Mast cells play an important role in the lung in both health and disease. Their primary role is to initiate an appropriate program of inflammation and repair in response to tissue damage initiated by a variety of diverse stimuli. They are important for host immunity against bacterial infection and potentially in the host immune response to non small cell lung cancer. In situations of ongoing tissue damage, the sustained release of numerous pro-inflammatory mediators, proteases and cytokines, contributes to the pathophysiology of lung diseases such as asthma and interstitial lung disease. A key goal is the development of treatments which attenuate adverse mast cell function when administered chronically to humans in vivo. Such therapies may offer a novel approach to the treatment of many life-threatening diseases.


Mast Cell Respiratory Syncytial Virus Stem Cell Factor Human Mast Cell Toluene Diisoc Yanate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Weller CL, Collington SJ, Hartneil A et al. Chemotactic action of prostaglandin E2 on mouse mast cells acting via the PGE2 receptor 3. Proc Natl Acad Sci USA 2007; 104:11712–11717.PubMedGoogle Scholar
  2. 2.
    Jones TG, Hallgren J, Humbles A et al. Antigen-induced increases in pulmonary mast cell progenitor numbers depend on IL-9 and CD1d-restricted NKT cells. J Immunol 2009; 183:5251–5260.PubMedGoogle Scholar
  3. 3.
    Roviezzo F, D’Agostino B, Brancaleone V et al. Systemic Administration of Sphingosine-1-phosphate Increases Bronchial Hyper-responsiveness in the Mouse. Am J Respir Cell Mol Biol 2009; [Epub ahead of print].Google Scholar
  4. 4.
    Weiler CL, Collington SJ, Brown JK et al. Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors. J Exp Med 2005; 201:1961–1971.Google Scholar
  5. 5.
    Brightling CE, Ammit AJ, Kaur D et al. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med 2005; 171:1103–1108.PubMedGoogle Scholar
  6. 6.
    Bradding P. Human lung mast cell heterogeneity. Thorax 2009; 64:278–280.PubMedGoogle Scholar
  7. 7.
    Weidner N, Austen KF. Heterogeneity of mast cells at multiple body sites. Fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase and carboxypeptidase content. Pathol Res Pract 1993; 189:156–162.PubMedGoogle Scholar
  8. 8.
    Irani AM, Goldstein SM, Wintroub BU et al. Human mast cell carboxypeptidase. Selective localization to MCTC cells. J Immunol 1991; 147:247–253.PubMedGoogle Scholar
  9. 9.
    Bradding P, Okayama Y, Howarth PH et al. Heterogeneity of human mast cells based on cytokine content. J Immunol 1995; 155:297–307.PubMedGoogle Scholar
  10. 10.
    Oskeritzian CA, Zhao W, Min HK et al. Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell. J Allergy Clin Immunol 2005; 115:1162–1168.PubMedGoogle Scholar
  11. 11.
    Brightling CE, Kaur D, Berger P et al. Differential expression of CCR3 and CXCR3 by human lung and bone marrow-derived mast cells: implications for tissue mast cell migration. J Leukoc Biol 2005; 77:759–766.PubMedGoogle Scholar
  12. 12.
    Saito H, Matsumoto K, Okumura S et al. Gene expression profiling of human mast cell subtypes: an in silico study. Allergol Int 2006; 55:173–179.PubMedGoogle Scholar
  13. 13.
    Balzar S, Chu HW, Strand M et al. Relationship of small airway chymase-positive mast cells and lung function in severe asthma. Am J Respir Crit Care Med 2005; 171:431–439.PubMedGoogle Scholar
  14. 14.
    Schulman ES, Kagey-Sobotka A, MacGlashan DW, Jr. et al. Heterogeneity of human mast cells. J Immunol 1983; 131:1936–1941.PubMedGoogle Scholar
  15. 15.
    Schulman ES, Pollack RB, Post TJ et al. Histochemical heterogeneity of dispersed human lung mast cells. J Immunol 1990; 144:4195–4201.PubMedGoogle Scholar
  16. 16.
    Andersson CK, Mori M, Bjermer L et al. Novel site-specific mast cell subpopulations in the human lung. Thorax 2009; 64:297–305.PubMedGoogle Scholar
  17. 17.
    Schechter NM, Irani AM, Sprows JL et al. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell. J Immunol 1990; 145:2652–2661.PubMedGoogle Scholar
  18. 18.
    Romagnani P, De Paulis A, Beltrame C et al. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am J Pathol 1999; 155:1195–1204.PubMedGoogle Scholar
  19. 19.
    Irani AM, Bradford TR, Kepley CL et al. Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem 1989; 37:1509–1515.PubMedGoogle Scholar
  20. 20.
    Hsieh FH, Sharma P, Gibbons A et al. Human airway epithelial cell determinants of survival and functional phenotype for primary human mast cells. Proc Natl Acad Sci USA 2005; 102:14380–14385.PubMedGoogle Scholar
  21. 21.
    Mierke CT, Ballmaier M, Werner U et al. Human endothelial cells regulate survival and proliferation of human mast cells. J Exp Med 2000; 192:801–811.PubMedGoogle Scholar
  22. 22.
    Malaviya R, Ross EA, MacGregor JI et al. Mast cell phagocytosis of FimH-expressing enterobacteria. JImmunol 1994; 152:1907–1914.Google Scholar
  23. 23.
    Malaviya R, Ikeda T, Ross E et al. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996; 381:77–80.PubMedGoogle Scholar
  24. 24.
    Sutherland RE, Olsen JS, McKinstry A et al. Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing. J Immunol 2008; 181:5598–5605.PubMedGoogle Scholar
  25. 25.
    Xu X, Zhang D, Lyubynska N et al. Mast cells protect mice from Mycoplasma pneumonia. Am J Respir Crit Care Med 2006; 173:219–225.PubMedGoogle Scholar
  26. 26.
    Hoek KL, Cassell GH, Duffy LB et al. Mycoplasma pneumoniae-induced activation and cytokine production in rodent mast cells. J Allergy Clin Immunol 2002; 109:470–476.PubMedGoogle Scholar
  27. 27.
    Luo D, Dai Y, Duffy LB et al. Inhibition of message for FcepsilonRI alpha chain blocks mast cell IL-4 production induced by coculture with Mycoplasma pneumoniae. Microb Pathog 2008; 44:286–292.PubMedGoogle Scholar
  28. 28.
    Laichalk LL, Kunkel SL, Strieter RM et al. Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect Immun 1996; 64:5211–5218.PubMedGoogle Scholar
  29. 29.
    Kerr AR, Irvine JJ, Search JJ et al. Role of inflammatory mediators in resistance and susceptibility to pneumococcal infection. Infect Immun 2002; 70:1547–1557.PubMedGoogle Scholar
  30. 30.
    Ketavarapu JM, Rodriguez AR, Yu JJ et al. Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4. Proc Natl Acad Sci USA 2008; 105:9313–9318.PubMedGoogle Scholar
  31. 31.
    Thakurdas SM, Melicoff E, Sansores-Garcia L et al. The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections. J Biol Chem 2007; 282:20809–20815.PubMedGoogle Scholar
  32. 32.
    Huang C, De Sanctis GT, O’Brien PJ et al. Evaluation of the substrate specificity of human mast cell tryptase beta I and demonstration of its importance in bacterial infections of the lung. J Biol Chem 2001; 276:26276–26284.PubMedGoogle Scholar
  33. 33.
    Shin K, Nigrovic PA, Crish J et al. Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. J Immunol 2009; 182:647–656.PubMedGoogle Scholar
  34. 34.
    Alho OP, Karttunen TJ, Karttunen R et al. Lymphocyte and mast cell counts are increased in the nasal mucosa in symptomatic natural colds. Clin Exp Immunol 2003; 131:138–142.PubMedGoogle Scholar
  35. 35.
    Kulka M, Alexopoulou L, Flavell RA et al. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol 2004; 114:174–182.PubMedGoogle Scholar
  36. 36.
    Shirato K, Taguchi F. Mast cell degranulation is induced by A549 airway epithelial cell infected with respiratory syncytial virus. Virology 2009; 386:88–93.PubMedGoogle Scholar
  37. 37.
    Dakhama A, Park JW, Taube C et al. The role of virus-specific immunoglobulin E in airway hyperresponsiveness. Am J Respir Crit Care Med 2004; 170:952–959.PubMedGoogle Scholar
  38. 38.
    Heib V, Becker M, Taube C et al. Advances in the understanding of mast cell function. Br J Haematol 2008; 142:683–694.PubMedGoogle Scholar
  39. 39.
    Wedde-Beer K, Hu C, Rodriguez MM et al. Leukotrienes mediate neurogenic inflammation in lungs of young rats infected with respiratory syncytial virus. Am J Physiol Lung Cell Mol Physiol 2002; 282:L1143–L1150.PubMedGoogle Scholar
  40. 40.
    Becker Y. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy—a review. Virus Genes 2006; 33:235–252.PubMedGoogle Scholar
  41. 41.
    Grunewald SM, Hahn C, Wohlleben G et al. Infection with influenza a virus leads to flu antigen-induced cutaneous anaphylaxis in mice. J Invest Dermatol 2002; 118:645–651.PubMedGoogle Scholar
  42. 42.
    Dakhama A, Lee YM, Ohnishi H et al. Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice. J Allergy Clin Immunol 2009; 123:138–145 e5.PubMedGoogle Scholar
  43. 43.
    Seggev JS, Sedmak GV, Kurup VP. Isotype-specific antibody responses to acute Mycoplasma pneumoniae infection. Ann Allergy Asthma Immunol 1996; 77:67–73.PubMedGoogle Scholar
  44. 44.
    Kjaergard LL, Larsen FO, Norn S et al. Basophil-bound IgE and serum IgE directed against Haemophilus influenzae and Streptococcus pneumoniae in patients with chronic bronchitis during acute exacerbations. Apmis 1996; 104:61–67.PubMedGoogle Scholar
  45. 45.
    Emre U, Sokolovskaya N, Roblin PM et al. Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease. J Infect Dis 1995; 172:265–267.PubMedGoogle Scholar
  46. 46.
    Inomata N, Tomita H, Ikezawa Z et al. Differential gene expression profile between cord blood progenitor-derived and adult progenitor-derived human mast cells. Immunol Lett 2005; 98:265–271.PubMedGoogle Scholar
  47. 47.
    Kulka M, Metcalfe DD. TLR3 activation inhibits human mast cell attachment to fibronectin and vitronectin. Mol Immunol 2006; 43:1579–1586.PubMedGoogle Scholar
  48. 48.
    Ikeda RK, Miller M, Nayar J et al. Accumulation of peribronchial mast cells in a mouse model of ovalbumin allergen induced chronic airway inflammation: modulation by immunostimulatory DNA sequences. J Immunol 2003; 171:4860–4867.PubMedGoogle Scholar
  49. 49.
    Yoshioka M, Fukuishi N, Iriguchi S et al. Lipoteichoic acid downregulates FcepsilonRI expression on human mast cells through Toll-like receptor 2. J Allergy Clin Immunol 2007; 120:452–461.PubMedGoogle Scholar
  50. 50.
    Zaidi AK, Thangam ER, Ali H. Distinct roles of Ca2+ mobilization and G protein usage on regulation of Toll-like receptor function in human and murine mast cells. Immunology 2006; 119:412–420.PubMedGoogle Scholar
  51. 51.
    Carlos D, Frantz FG, Souza-Junior DA et al. TLR2-dependent mast cell activation contributes to the control of Mycobacterium tuberculosis infection. Microbes Infect 2009; 11:770–778.PubMedGoogle Scholar
  52. 52.
    Bradding P, Walls AF, Holgate ST. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol 2006; 117:1277–1284.PubMedGoogle Scholar
  53. 53.
    Bradding P. Mast cells in asthma. In: Busse WW, Holgate ST, eds. Asthma and rhinitis. Boston: Blackwell Scientific Publications Inc, 2000:319–338.Google Scholar
  54. 54.
    Newson R, Strachan D, Archibald E et al. Effect of thunderstorms and airborne grass pollen on the incidence of acute asthma in England, 1990–94. Thorax 1997; 52:680–685.PubMedGoogle Scholar
  55. 55.
    Newson R, Strachan D, Archibald E et al. Acute asthma epidemics, weather and pollen in England, 1987–1994. Eur Respir J 1998; 11:694–701.PubMedGoogle Scholar
  56. 56.
    Schleimer RP, MacGlashan DW, Jr., Peters SP et al. Characterization of inflammatory mediator release from purified human lung mast cells. Am Rev Respir Dis 1986; 133:614–617.PubMedGoogle Scholar
  57. 57.
    Casale TB, Wood D, Richerson HB et al. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness. J Clin Invest 1987; 79:1197–1203.PubMedGoogle Scholar
  58. 58.
    Wenzel SE, Fowler AA, 3rd, Schwartz LB. Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma. Am Rev Respir Dis 1988; 137:1002–1008.PubMedGoogle Scholar
  59. 59.
    Murray JJ, Tonnel AB, Brash AR et al. Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med 1986; 315:800–804.PubMedGoogle Scholar
  60. 60.
    Wenzel SE, Larsen GL, Johnston K et al. Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am Rev Respir Dis 1990; 142:112–119.PubMedGoogle Scholar
  61. 61.
    Wenzel SE, Westcott JY, Larsen GL. Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: relationship to the development of late asthmatic responses. J Allergy Clin Immunol 1991; 87:540–548.PubMedGoogle Scholar
  62. 62.
    Liu MC, Hubbard WC, Proud D et al. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator and permeability changes. Am Rev Respir Dis 1991; 144:51–58.PubMedGoogle Scholar
  63. 63.
    Sedgwick JB, Calhoun WJ, Gleich GJ et al. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am Rev Respir Dis 1991; 144:1274–12781.PubMedGoogle Scholar
  64. 64.
    Rafferty P, Beasley R, Holgate ST. The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5′ monophosphate in atopic asthma. Am Rev Respir Dis 1987; 136:369–373.PubMedGoogle Scholar
  65. 65.
    Curzen N, Rafferty P, Holgate ST. Effects of a cyclo-oxygenase inhibitor, flurbiprofen and an H1 histamine receptor antagonist, terfenadine, alone and in combination on allergen induced immediate bronchoconstriction in man. Thorax 1987; 42:946–952.PubMedGoogle Scholar
  66. 66.
    Taylor IK, O’Shaughnessy KM, Fuller RW et al. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet 1991; 337:690–694.PubMedGoogle Scholar
  67. 67.
    Findlay SR, Barden JM, Easley CB et al. Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma. J Allergy Clin Immunol 1992; 89:1040–1045.PubMedGoogle Scholar
  68. 68.
    Beasley R, Varley J, Robinson C et al. Cholinergic-mediated bronchoconstriction induced by prostaglandin D2, its initial metabolite 9 alpha, 11 beta-PGF2 and PGF2 alpha in asthma. Am Rev Respir Dis 1987; 136:1140–1144.PubMedGoogle Scholar
  69. 69.
    Church MK, Hiroi J. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol 1987; 90:421–429.PubMedGoogle Scholar
  70. 70.
    Pepys J, Hargreave FE, Chan M et al. Inhibitory effects of disodium cromoglycate on allergen-inhalation tests. Lancet 1968; 2:134–137.PubMedGoogle Scholar
  71. 71.
    Howarth PH, Durham SR, Lee TH et al. Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma. Am Rev Respir Dis 1985; 132:986–992.PubMedGoogle Scholar
  72. 72.
    Fahy JV, Fleming HE, Wong HH et al. The effect of an anti-IgE monoclonal antibody on the early-and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997; 155:1828–1834.PubMedGoogle Scholar
  73. 73.
    Boulet LP, Chapman KR, Cote J et al. Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med 1997; 155:1835–1840.PubMedGoogle Scholar
  74. 74.
    De Monchy JG, Kauffman HF, Venge P et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985; 131:373–376.PubMedGoogle Scholar
  75. 75.
    Metzger WJ, Zavala D, Richerson HB et al. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway inflammation. Am Rev Respir Dis 1987; 135:433–440.PubMedGoogle Scholar
  76. 76.
    Bentley AM, Meng Q, Robinson DS et al. Increases in activated T-lymphocytes, eosinophils and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol 1993; 8:35–42.PubMedGoogle Scholar
  77. 77.
    Montefort S, Gratziou C, Goulding D et al. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J Clin Invest 1994; 93:1411–1421.PubMedGoogle Scholar
  78. 78.
    Tonnel AB, Joseph M, Gosset P et al. Stimulation of alveolar macrophages in asthmatic patients after local provocation test. Lancet 1983; 1:1406–1408.PubMedGoogle Scholar
  79. 79.
    Diaz P, Gonzalez MC, Galleguillos FR et al. Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions. Am Rev Respir Dis 1989; 139:1383–1389.PubMedGoogle Scholar
  80. 80.
    Kirby JG, Hargreave FE, Gleich GJ et al. Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis 1987; 136:379–383.PubMedGoogle Scholar
  81. 81.
    Flint KC, Leung KB, Hudspith BN et al. Bronchoalveolar mast cells in extrinsic asthma: amechanism for the initiation of antigen specific bronchoconstriction. Br Med J (Clin Res Ed) 1985; 291:923–926.Google Scholar
  82. 82.
    Broide DH, Gleich GJ, Cuomo AJ et al. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol 1991; 88:637–648.PubMedGoogle Scholar
  83. 83.
    Casolaro V, Galeone D, Giacummo A et al. Human basophil/mast cell releasability. V. Functional comparisons of cells obtained from peripheral blood, lung parenchyma and bronchoalveolar lavage in asthmatics. Am Rev Respir Dis 1989; 139:1375–1382.PubMedGoogle Scholar
  84. 84.
    Wardlaw AJ, Dunnette S, Gleich GJ et al. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988; 137:62–69.PubMedGoogle Scholar
  85. 85.
    Beasley R, Roche WR, Roberts JA et al. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139:806–817.PubMedGoogle Scholar
  86. 86.
    Djukanovic R, Lai CK, Wilson JW et al. Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls. Eur Respir J 1992; 5:538–544.PubMedGoogle Scholar
  87. 87.
    Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993; 147:697–704.PubMedGoogle Scholar
  88. 88.
    Bradding P, Roberts JA, Britten KM et al. Interleukin-4,-5 and-6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10:471–480.PubMedGoogle Scholar
  89. 89.
    Ying S, Durham SR, Corrigan CJ et al. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell Mol Biol 1995; 12:477–487.PubMedGoogle Scholar
  90. 90.
    Ying S, Humbert M, Barkans J et al. Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T-cells, eosinophils and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1997; 158:3539–3544.PubMedGoogle Scholar
  91. 91.
    Saetta M, Di Stefano A, Maestrelli P et al. Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis 1992; 145:160–168.PubMedGoogle Scholar
  92. 92.
    Humbert M, Grant JA, Taborda-Barata L et al. High-affinity IgE receptor (FcepsilonRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Respir Crit Care Med 1996; 153:1931–1937.PubMedGoogle Scholar
  93. 93.
    Di Stefano A, Saetta M, Maestrelli P et al. Mast cells in the airway mucosa and rapid development of occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis 1993; 147:1005–1009.PubMedGoogle Scholar
  94. 94.
    Chan-Yeung M, Chan H, Tse KS et al. Histamine and leukotrienes release in bronchoalveolar fluid during plicatic acid-induced bronchoconstriction. J Allergy Clin Immunol 1989; 84:762–768.PubMedGoogle Scholar
  95. 95.
    Frew A, Chan H, Dryden P et al. Immunologic studies of the mechanisms of occupational asthma caused by western red cedar. J Allergy Clin Immunol 1993; 92:466–478.PubMedGoogle Scholar
  96. 96.
    Carroll NG, Mutavdzic S, James AL. Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur Respir J 2002; 19:879–885.PubMedGoogle Scholar
  97. 97.
    Chen FH, Samson KT, Miura K et al. Airway remodeling: a comparison between fatal and nonfatal asthma. J Asthma 2004; 41:631–638.PubMedGoogle Scholar
  98. 98.
    Brightling CE, Bradding P, Symon FA et al. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002; 346:1699–1705.PubMedGoogle Scholar
  99. 99.
    Zanini A, Chetta A, Saetta M et al. Chymase-positive mast cells play a role in the vascular component of airway remodeling in asthma. J Allergy Clin Immunol 2007; 120:329–333.PubMedGoogle Scholar
  100. 100.
    Shiang C, Mauad T, Senhorini A et al. Pulmonary periarterial inflammation in fatal asthma. Clin Exp Allergy 2009; 39:1499–1507.PubMedGoogle Scholar
  101. 101.
    Brightling CE, Symon FA, Holgate ST et al. Interleukin-4 and-13 expression is colocalized to mast cells within the airway smooth muscle in asthma. Clin Exp Allergy 2003; 33:1711–1716.PubMedGoogle Scholar
  102. 102.
    Amin K, Janson C, Harvima I et al. CC chemokine receptors CCR1 and CCR4 are expressed on airway mast cells in allergic asthma. J Allergy Clin Immunol 2005; 116:1383–1386.PubMedGoogle Scholar
  103. 103.
    Okumura S, Sagara H, Fukuda T et al. FcepsilonRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells. J Allergy Clin Immunol 2005; 115:272–279.PubMedGoogle Scholar
  104. 104.
    Okayama Y, Okumura S, Sagara H et al. FcepsilonRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells. Eur Respir J 2009; 34:425–435.PubMedGoogle Scholar
  105. 105.
    Siddiqui S, Mistry V, Doe C et al. Airway hyperresponsiveness is dissociated from airway wall structural remodeling. J Allergy Clin Immunol 2008; 122:335–341, 41 e1-3.PubMedGoogle Scholar
  106. 106.
    Carroll NG, Mutavdzic S, James AL. Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma. Thorax 2002; 57:677–682.PubMedGoogle Scholar
  107. 107.
    Andersson CK, Mori M, Bjermer L et al. Alterations in Lung Mast Cell Populations in Patients with COPD. Am J Respir Crit Care Med 2009.Google Scholar
  108. 108.
    Saha S, Mistry V, Siva R et al. Induced sputum and bronchial mucosal expression of interleukin-13 is not increased in chronic obstructive pulmonary disease. Allergy 2008; 63:1239–1243.PubMedGoogle Scholar
  109. 109.
    Gosman MM, Postma DS, Vonk JM et al. Association of mast cells with lung function in chronic obstructive pulmonary disease. Respir Res 2008; 9:64.PubMedGoogle Scholar
  110. 110.
    Pesci A, Bertorelli G, Gabrielli M et al. Mast cells in fibrotic lung disorders. Chest 1993; 103:989–996.PubMedGoogle Scholar
  111. 111.
    Kawanami O, Ferrans VJ, Fulmer JD et al. Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab Invest 1979; 40:717–734.PubMedGoogle Scholar
  112. 112.
    Pesci A, Majori M, Piccoli ML et al. Mast cells in bronchiolitis obliterans organizing pneumonia. Mast cell hyperplasia and evidence for extracellular release of tryptase. Chest 1996; 110:383–391.PubMedGoogle Scholar
  113. 113.
    Hirata K, Sugama Y, Ikura Y et al. Enhanced mast cell chymase expression in human idiopathic interstitial pneumonia. Int J Mol Med 2007; 19:565–570.PubMedGoogle Scholar
  114. 114.
    Qu Z, Liebler JM, Powers MR et al. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 1995; 147:564–573.PubMedGoogle Scholar
  115. 115.
    Inoue Y, King TE, Jr., Tinkle SS et al. Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders. Am J Pathol 1996; 149:2037–2054.PubMedGoogle Scholar
  116. 116.
    Inoue Y, King TE, Jr., Barker E et al. Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis. Am J Respir Crit Care Med 2002; 166:765–773.PubMedGoogle Scholar
  117. 117.
    Haldar P, Brightling CE, Hargadon B et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009; 360:973–984.PubMedGoogle Scholar
  118. 118.
    Brightling CE, Ward R, Goh KL et al. Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med 1999; 160:406–410.PubMedGoogle Scholar
  119. 119.
    Brightling CE, Ward R, Woltmann G et al. Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma. Am J Respir Crit Care Med 2000; 162:878–882.PubMedGoogle Scholar
  120. 120.
    Brightling CE, Symon FA, Birring SS et al. TH2 cytokine expression in bronchoalveolar lavage fluid T-lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. J Allergy Clin Immunol 2002; 110:899–905.PubMedGoogle Scholar
  121. 121.
    Brightling CE, Symon FA, Birring SS et al. Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax 2003; 58:528–532.PubMedGoogle Scholar
  122. 122.
    Berry M, Morgan A, Shaw DE et al. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax 2007; 62:1043–1049.PubMedGoogle Scholar
  123. 123.
    Begueret H, Berger P, Vernejoux JM et al. Inflammation of bronchial smooth muscle in allergic asthma. Thorax 2007; 62:8–15.PubMedGoogle Scholar
  124. 124.
    Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001; 107:191–193.PubMedGoogle Scholar
  125. 125.
    Venkayya R, Lam M, Willkom M et al. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol 2002; 26:202–208.PubMedGoogle Scholar
  126. 126.
    Sekizawa K, Caughey GH, Lazarus SC et al. Mast cell tryptase causes airway smooth muscle hyperresponsiveness in dogs. J Clin Invest 1989; 83:175–179.PubMedGoogle Scholar
  127. 127.
    Molinari JF, Scuri M, Moore WR et al. Inhaled tryptase causes bronchoconstriction in sheep via histamine release. Am J Respir Crit Care Med 1996; 154:649–653.PubMedGoogle Scholar
  128. 128.
    Berger P, Perng DW, Thabrew H et al. Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells. J Appl Physiol 2001; 91:1372–1379.PubMedGoogle Scholar
  129. 129.
    Brown JK, Jones CA, Rooney LA et al. Tryptase’s potent mitogenic effects in human airway smooth muscle cells are via nonproteolytic actions. Am J Physiol Lung Cell Mol Physiol 2002; 282:L197–L206.PubMedGoogle Scholar
  130. 130.
    Kaur D, Hollins F, Saunders R et al. Airway smooth muscle proliferation and survival is not modulated by mast cells. Clin Exp Allergy 2009.Google Scholar
  131. 131.
    Woodman L, Siddiqui S, Cruse G et al. Mast cells promote airway smooth muscle cell differentiation via autocrine up-regulation of TGF-beta 1. J Immunol 2008; 181:5001–5007.PubMedGoogle Scholar
  132. 132.
    Veerappan A, Reid AC, Estephan R et al. Mast cell renin and a local renin-angiotensin system in the airway: role in bronchoconstriction. Proc Natl Acad Sci USA 2008; 105:1315–1320.PubMedGoogle Scholar
  133. 133.
    Lazaar AL, Plotnick MI, Kucich U et al. Mast cell chymase modifies cell-matrix interactions and inhibits mitogen-induced proliferation of human airway smooth muscle cells. J Immunol 2002; 169:1014–1020.PubMedGoogle Scholar
  134. 134.
    Waern I, Jonasson S, Hjoberg J et al. Mouse mast cell protease 4 is the major chymase in murine airways and has a protective role in allergic airway inflammation. J Immunol 2009; 183:6369–6376.PubMedGoogle Scholar
  135. 135.
    Yang W, Kaur D, Okayama Y et al. Human lung mast cells adhere to human airway smooth muscle, in part, via tumor suppressor in lung cancer-1. J Immunol 2006; 176:1238–1243.PubMedGoogle Scholar
  136. 136.
    Hollins F, Kaur D, Yang W et al. Human airway smooth muscle promotes human lung mast cell survival, proliferation and constitutive activation: cooperative roles for CADM1, stem cell factor and IL-6. J Immunol 2008; 181:2772–2780.PubMedGoogle Scholar
  137. 137.
    Pesci A, Foresi A, Bertorelli G et al. Histochemical characteristics and degranulation of mast cells in epithelium and lamina propria of bronchial biopsies from asthmatic and normal subjects. Am Rev Respir Dis 1993; 147:684–689.PubMedGoogle Scholar
  138. 138.
    Rauter I, Krauth MT, Flicker S et al. Allergen cleavage by effector cell-derived proteases regulates allergic inflammation. FASEB J 2006; 20:967–969.PubMedGoogle Scholar
  139. 139.
    Rauter I, Krauth MT, Westritschnig K et al. Mast cell-derived proteases control allergic inflammation through cleavage of IgE. J Allergy Clin Immunol 2008; 121:197–202.PubMedGoogle Scholar
  140. 140.
    Sanmugalingam D, Wardlaw AJ, Bradding P. Adhesion of human lung mast cells to bronchial epithelium: evidence for a novel carbohydrate-mediated mechanism. J Leukoc Biol 2000; 68:38–46.PubMedGoogle Scholar
  141. 141.
    Cairns JA, Walls AF. Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J Immunol 1996; 156:275–283.PubMedGoogle Scholar
  142. 142.
    Yang W, Wardlaw AJ, Bradding P. Attenuation of human lung mast cell degranulation by bronchial epithelium. Allergy 2006; 61:569–575.PubMedGoogle Scholar
  143. 143.
    Cutz E, Levison H, Cooper DM. Ultrastructure of airways in children with asthma. Histopathology 1978; 2:407–421.PubMedGoogle Scholar
  144. 144.
    Wang SW, Oh CK, Cho SH et al. Amphiregulin expression in human mast cells and its effect on the primary human lung fibroblasts. J Allergy Clin Immunol 2005; 115:287–294.PubMedGoogle Scholar
  145. 145.
    Enomoto Y, Orihara K, Takamasu T et al. Tissue remodeling induced by hypersecreted epidermal growth factor and amphiregulin in the airway after an acute asthma attack. J Allergy Clin Immunol 2009; 124:913–920 e1-7.PubMedGoogle Scholar
  146. 146.
    Kalesnikoff J, Huber M, Lam V et al. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 2001; 14:801–811.PubMedGoogle Scholar
  147. 147.
    Kitaura J, Song J, Tsai M et al. Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI. Proc Natl Acad Sci USA 2003; 100:12911–12916.PubMedGoogle Scholar
  148. 148.
    Pandey V, Mihara S, Fensome-Green A et al. Monomeric IgE stimulates NFAT translocation into the nucleus, a rise in cytosol Ca2+, degranulation and membrane ruffling in the cultured rat basophilic leukemia-2H3 mast cell line. J Immunol 2004; 172:4048–4058.PubMedGoogle Scholar
  149. 149.
    Oka T, Hori M, Tanaka A et al. IgE alone-induced actin assembly modifies calcium signaling and degranulation in RBL-2H3 mast cells. Am J Physiol Cell Physiol 2004; 286:C256–C263.PubMedGoogle Scholar
  150. 150.
    Cruse G, Kaur D, Yang W et al. Activation of human lung mast cells by monomeric immunoglobulin E. Eur Respir J 2005; 25:858–863.PubMedGoogle Scholar
  151. 151.
    Cruse G, Cockerill S, Bradding P. IgE alone promotes human lung mast cell survival through the autocrine production of IL-6. BMC Immunol 2008; 9:2.PubMedGoogle Scholar
  152. 152.
    Burrows B, Martinez FD, Halonen M et al. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989; 320:271–277.PubMedGoogle Scholar
  153. 153.
    Sears MR, Burrows B, Flannery EM et al. Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N Engl J Med 1991; 325:1067–1071.PubMedGoogle Scholar
  154. 154.
    Sunyer J, Anto JM, Sabria J et al. Relationship between serum IgE and airway responsiveness in adults with asthma. J Allergy Clin Immunol 1995; 95:699–706.PubMedGoogle Scholar
  155. 155.
    Sunyer J, Anto JM, Castellsague J et al. Total serum IgE is associated with asthma independently of specific IgE levels. The Spanish Group of the European Study of Asthma. Eur Respir J 1996; 9:1880–1884.PubMedGoogle Scholar
  156. 156.
    Djukanovic R, Wilson SJ, Kraft M et al. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care Med 2004; 170:583–593.PubMedGoogle Scholar
  157. 157.
    Columbo M, Horowitz EM, Botana LM et al. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 1992; 149:599–608.PubMedGoogle Scholar
  158. 158.
    Al-Muhsen SZ, Shablovsky G, Olivenstein R et al. The expression of stem cell factor and c-kit receptor in human asthmatic airways. Clin Exp Allergy 2004; 34:911–916.PubMedGoogle Scholar
  159. 159.
    Da Silva CA, Blay F, Israel-Biet D et al. Effect of glucocorticoids on stem cell factor expression in human asthmatic bronchi. Clin Exp Allergy 2006; 36:317–324.PubMedGoogle Scholar
  160. 160.
    Chong LK, Suvarna K, Chess-Williams R et al. Desensitization of beta2-adrenoceptor-mediated responses by short-acting beta2-adrenoceptor agonists in human lung mast cells. Br J Pharmacol 2003; 138:512–520.PubMedGoogle Scholar
  161. 161.
    Giannini D, Carletti A, Dente FL et al. Tolerance to the protective effect of salmeterol on allergen challenge. Chest 1996; 110:1452–1457.PubMedGoogle Scholar
  162. 162.
    Swystun VA, Gordon JR, Davis EB et al. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. J Allergy Clin Immunol 2000; 106:57–64.PubMedGoogle Scholar
  163. 163.
    Taylor DR, Sears MR, Herbison GP et al. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function. Thorax 1993; 48:134–138.PubMedGoogle Scholar
  164. 164.
    Taylor DR, Town GI, Herbison GP et al. Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol. Thorax 1998; 53:744–752.PubMedGoogle Scholar
  165. 165.
    Cruse G, Yang W, Duffy SM et al. Counterregulation of beta(2)-adrenoceptor function in human mast cells by stem cell factor. J Allergy Clin Immunol 2010; 125:257–263.PubMedGoogle Scholar
  166. 166.
    Elliot JG, Abramson MJ, Drummer OH et al. Time to death and mast cell degranulation in fatal asthma. Respirology 2009; 14:808–813.PubMedGoogle Scholar
  167. 167.
    Marc MM, Korosec P, Kosnik M et al. Complement factors c3a, c4a and c5a in chronic obstructive pulmonary disease and asthma. Am J Respir Cell Mol Biol 2004; 31:216–219.PubMedGoogle Scholar
  168. 168.
    Nigo YI, Yamashita M, Hirahara K et al. Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function. Proc Natl Acad Sci USA 2006; 103:2286–2291.PubMedGoogle Scholar
  169. 169.
    Murakami D, Yamada H, Yajima T et al. Lipopolysaccharide inhalation exacerbates allergic airway inflammation by activating mast cells and promoting Th2 responses. Clin Exp Allergy 2007; 37:339–347.PubMedGoogle Scholar
  170. 170.
    Okumura S, Kashiwakura J, Tomita H et al. Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcepsilonRI. Blood 2003; 102:2547–2554.PubMedGoogle Scholar
  171. 171.
    Kato A, Favoreto S, Jr., Avila PC et al. TLR3-and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J Immunol 2007; 179:1080–1087.PubMedGoogle Scholar
  172. 172.
    Allakhverdi Z, Comeau MR, Jessup HK et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 2007; 204:253–258.PubMedGoogle Scholar
  173. 173.
    Zhou B, Comeau MR, De Smedt T et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol 2005; 6:1047–1053.PubMedGoogle Scholar
  174. 174.
    Ito T, Wang YH, Duramad O et al. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 2005; 202:1213–1223.PubMedGoogle Scholar
  175. 175.
    Seshasayee D, Lee WP, Zhou M et al. In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation. J Clin Invest 2007; 117:3868–3878.PubMedGoogle Scholar
  176. 176.
    Miyata M, Hatsushika K, Ando T et al. Mast cell regulation of epithelial TSLP expression plays an important role in the development of allergic rhinitis. Eur J Immunol 2008; 38:1487–1492.PubMedGoogle Scholar
  177. 177.
    Ying S, O’Connor B, Ratoff J et al. Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. J Immunol 2008; 181:2790–2798.PubMedGoogle Scholar
  178. 178.
    Ying S, O’Connor B, Ratoff J et al. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol 2005; 174:8183–8190.PubMedGoogle Scholar
  179. 179.
    Redegeld FA, van der Heijden MW, Kool M et al. Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses. Nat Med 2002; 8:694–701.PubMedGoogle Scholar
  180. 180.
    Kraneveld AD, Kool M, van Houwelingen AH et al. Elicitation of allergic asthma by immunoglobulin free light chains. Proc Natl Acad Sci USA 2005; 102:1578–1583.PubMedGoogle Scholar
  181. 181.
    Huber M, Helgason CD, Damen JE et al. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc Natl Acad Sci USA 1998; 95:11330–11335.PubMedGoogle Scholar
  182. 182.
    Vonakis BM, Gibbons S, Jr., Sora R et al. Src homology 2 domain-containing inositol 5′ phosphatase is negatively associated with histamine release to human recombinant histamine-releasing factor in human basophils. J Allergy Clin Immunol 2001; 108:822–831.PubMedGoogle Scholar
  183. 183.
    Dudler T, Machado DC, Kolbe L et al. A link between catalytic activity, IgE-independent mast cell activation and allergenicity of bee venom phospholipase A2. J Immunol 1995; 155:2605–2613.PubMedGoogle Scholar
  184. 184.
    Machado DC, Horton D, Harrop R et al. Potential allergens stimulate the release of mediators of the allergic response from cells of mast cell lineage in the absence of sensitization with antigen-specific IgE. Eur J Immunol 1996; 26:2972–2980.PubMedGoogle Scholar
  185. 185.
    Huels C, Germann T, Goedert S et al. Co-activation of naive CD4+ T-cells and bone marrow-derived mast cells results in the development of Th2 cells. Int Immunol 1995; 7:525–532.PubMedGoogle Scholar
  186. 186.
    Pawankar R, Okuda M, Yssel H et al. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4 and IL-13 and can induce IgE synthesis in B cells. J Clin Invest 1997; 99:1492–1499.PubMedGoogle Scholar
  187. 187.
    Williams CM, Galli SJ. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med 2000; 192:455–462.PubMedGoogle Scholar
  188. 188.
    Taube C, Wei X, Swasey CH et al. Mast cells, Fc epsilon RI and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant. J Immunol 2004; 172:6398–6406.PubMedGoogle Scholar
  189. 189.
    Yu M, Tsai M, Tam SY et al. Mast cells can promote the development of multiple features of chronic asthma in mice. J Clin Invest 2006; 116:1633–1641.PubMedGoogle Scholar
  190. 190.
    Wang B, Huang X, Wolters PJ et al. Cutting edge: Deficiency of macrophage migration inhibitory factor impairs murine airway allergic responses. J Immunol 2006; 177:5779–5784.PubMedGoogle Scholar
  191. 191.
    Cyphert JM, Kovarova M, Allen IC et al. Cooperation between mast cells and neurons is essential for antigen-mediated bronchoconstriction. J Immunol 2009; 182:7430–7439.PubMedGoogle Scholar
  192. 192.
    van Houwelingen AH, Kool M, de Jager SC et al. Mast cell-derived TNF-alpha primes sensory nerve endings in a pulmonary hypersensitivity reaction. J Immunol 2002; 168:5297–5302.PubMedGoogle Scholar
  193. 193.
    Wessler I, Holper B, Kortsik C et al. Dysfunctional inhibitory muscarinic receptors mediate enhanced histamine release in isolated human bronchi. Life Sci 2007; 80:2294–2297.PubMedGoogle Scholar
  194. 194.
    Strieter RM. Pathogenesis and natural history of usual interstitial pneumonia: the whole story or the last chapter of a long novel. Chest 2005; 128:526S–532S.PubMedGoogle Scholar
  195. 195.
    Zhang K, Rekhter MD, Gordon D et al. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol 1994; 145:114–125.PubMedGoogle Scholar
  196. 196.
    Heard BE, Dewar A, Corrin B. Apposition of fibroblasts to mast cells and lymphocytes in normal human lung and in cryptogenic fibrosing alveolitis. Ultrastructure and cell perimeter measurements. J Pathol 1992; 166:303–310.PubMedGoogle Scholar
  197. 197.
    Casale TB, Trapp S, Zehr B et al. Bronchoalveolar lavage fluid histamine levels in interstitial lung diseases. Am Rev Respir Dis 1988; 138:1604–1608.PubMedGoogle Scholar
  198. 198.
    Gonzalez NC, Allen J, Schmidt EJ et al. Role of the renin-angiotensin system in the systemic microvascular inflammation of alveolar hypoxia. Am J Physiol Heart Circ Physiol 2007; 292:H2285–H2294.PubMedGoogle Scholar
  199. 199.
    Subba Rao PV, Friedman MM, Atkins FM et al. Phagocytosis of mast cell granules by cultured fibroblasts. J Immunol 1983; 130:341–349.PubMedGoogle Scholar
  200. 200.
    Boucek RJ, Noble NL. Histamine, norepinephrine and bradykinin stimulation of fibroblast growth and modification of serotonin response. Proc Soc Exp Biol Med 1973; 144:929–933.PubMedGoogle Scholar
  201. 201.
    Jordana M, Befus AD, Newhouse MT et al. Effect of histamine on proliferation of normal human adult lung fibroblasts. Thorax 1988; 43:552–558.PubMedGoogle Scholar
  202. 202.
    Feghali CA, Bost KL, Boulware DW et al. Human recombinant interleukin-4 induces proliferation and interleukin-6 production by cultured human skin fibroblasts. Clin Immunol Immunopathol 1992; 63:182–187.PubMedGoogle Scholar
  203. 203.
    Sugarman BJ, Aggarwal BB, Hass PE et al. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science 1985; 230:943–945.PubMedGoogle Scholar
  204. 204.
    Hetzel M, Bachem M, Anders D et al. Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts. Lung 2005; 183:225–237.PubMedGoogle Scholar
  205. 205.
    Trautmann A, Feuerstein B, Ernst N et al. Heterotypic cell-cell adhesion of human mast cells to fibroblasts. Arch Dermatol Res 1997; 289:194–203.PubMedGoogle Scholar
  206. 206.
    Trautmann A, Krohne G, Brocker EB et al. Human mast cells augment fibroblast proliferation by heterotypic cell-cell adhesion and action of IL-4. J Immunol 1998; 160:5053–5057.PubMedGoogle Scholar
  207. 207.
    Bradding P, Feather IH, Wilson S et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5 and IL-6 in human allergic mucosal inflammation. J Immunol 1993; 151:3853–3865.PubMedGoogle Scholar
  208. 208.
    Postlethwaite AE, Seyer JM. Fibroblast chemotaxis induction by human recombinant interleukin-4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70–88 and 89–122. J Clin Invest 1991; 87:2147–2152.PubMedGoogle Scholar
  209. 209.
    Postlethwaite AE, Holness MA, Katai H et al. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest 1992; 90:1479–1485.PubMedGoogle Scholar
  210. 210.
    Gospodarowicz D, Cheng J, Lui GM et al. Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor. Proc Natl Acad Sci USA 1984; 81:6963–6967.PubMedGoogle Scholar
  211. 211.
    Yayon A, Klagsbrun M, Esko JD et al. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991; 64:841–848.PubMedGoogle Scholar
  212. 212.
    Folkman J, Klagsbrun M, Sasse J et al. A heparin-binding angiogenic protein—basic fibroblast growth factor—is stored within basement membrane. Am J Pathol 1988; 130:393–400.PubMedGoogle Scholar
  213. 213.
    Akers IA, Parsons M, Hill MR et al. Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2. Am J Physiol Lung Cell Mol Physiol 2000; 278:L193–L201.PubMedGoogle Scholar
  214. 214.
    Goto T, Befus D, Low R et al. Mast cell heterogeneity and hyperplasia in bleomycin-induced pulmonary fibrosis of rats. Am Rev Respir Dis 1984; 130:797–802.PubMedGoogle Scholar
  215. 215.
    Watanabe S, Watanabe K, Oishi T et al. Mast cells in the rat alveolar septa undergoing fibrosis after ionizing irradiation. Ultrastructural and histochemical studies. Lab Invest 1974; 31:555–567.PubMedGoogle Scholar
  216. 216.
    Wagner MM, Edwards RE, Moncrieff CB et al. Mast cells and inhalation of asbestos in rats. Thorax 1984; 39:539–544.PubMedGoogle Scholar
  217. 217.
    Suzuki N, Horiuchi T, Ohta K et al. Mast cells are essential for the full development of silica-induced pulmonary inflammation: a study with mast cell-deficient mice. Am J Respir Cell Mol Biol 1993;9:475–483.PubMedGoogle Scholar
  218. 218.
    Assaad AM, Kawut SM, Arcasoy SM et al. Platelet-derived growth factor is increased in pulmonary capillary hemangiomatosis. Chest 2007; 131:850–855.PubMedGoogle Scholar
  219. 219.
    O’Byrne KJ, Dalgleish AG. Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer 2001; 85:473–483.PubMedGoogle Scholar
  220. 220.
    Ribatti D, Crivellato E. The controversial role of mast cells in tumor growth. Int Rev Cell Mol Biol 2009; 275:89–131.PubMedGoogle Scholar
  221. 221.
    Theoharides TC, Conti P. Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol 2004; 25:235–241.PubMedGoogle Scholar
  222. 222.
    Takanami I, Takeuchi K, Naruke M. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer 2000; 88:2686–2692.PubMedGoogle Scholar
  223. 223.
    Imada A, Shijubo N, Kojima H et al. Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. Eur Respir J 2000; 15:1087–1093.PubMedGoogle Scholar
  224. 224.
    Nagata M, Shijubo N, Walls AF et al. Chymase-positive mast cells in small sized adenocarcinoma of the lung. Virchows Arch 2003; 443:565–573.PubMedGoogle Scholar
  225. 225.
    Ribatti D, Vacca A, Nico B et al. Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br J Cancer 1999; 79:451–455.PubMedGoogle Scholar
  226. 226.
    Coussens LM, Raymond WW, Bergers G et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 1999; 13:1382–1397.PubMedGoogle Scholar
  227. 227.
    Rudolph MI, Boza Y, Yefi R et al. The influence of mast cell mediators on migration of SW756 cervical carcinoma cells. J Pharmacol Sci 2008; 106:208–218.PubMedGoogle Scholar
  228. 228.
    Zudaire E, Martinez A, Garayoa M et al. Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis. Am J Pathol 2006; 168:280–291.PubMedGoogle Scholar
  229. 229.
    Tomita M, Matsuzaki Y, Onitsuka T. Effect of mast cells on tumor angiogenesis in lung cancer. Ann Thorac Surg 2000; 69:1686–1690.PubMedGoogle Scholar
  230. 230.
    Kojima H, Shijubo N, Abe S. Thymidine phosphorylase and vascular endothelial growth factor in patients with Stage I lung adenocarcinoma. Cancer 2002; 94:1083–1093.PubMedGoogle Scholar
  231. 231.
    Ibaraki T, Muramatsu M, Takai S et al. The relationship of tryptase-and chymase-positive mast cells to angiogenesis in stage I nonsmall cell lung cancer. Eur J Cardiothorac Surg 2005; 28:617–621.PubMedGoogle Scholar
  232. 232.
    Dundar E, Oner U, Peker BC et al. The significance and relationship between mast cells and tumour angiogenesis in nonsmall cell lung carcinoma. J Int Med Res 2008; 36:88–95.PubMedGoogle Scholar
  233. 233.
    Carlini MJ, Dalurzo MC, Lastiri JM et al. Mast cell phenotypes and microvessels in nonsmall cell lung cancer and its prognostic significance. Hum Pathol 2009.Google Scholar
  234. 234.
    Tataroglu C, Kargi A, Ozkal S et al. Association of macrophages, mast cells and eosinophil leukocytes with angiogenesis and tumor stage in nonsmall cell lung carcinomas (NSCLC). Lung Cancer 2004; 43:47–54.PubMedGoogle Scholar
  235. 235.
    Kojima H, Shijubo N, Yamada G et al. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma. Cancer 2005; 104:1668–1677.PubMedGoogle Scholar
  236. 236.
    Tomita M, Matsuzaki Y, Onitsuka T. Correlation between mast cells and survival rates in patients with pulmonary adenocarcinoma. Lung Cancer 1999; 26:103–108.PubMedGoogle Scholar
  237. 237.
    Welsh TJ, Green RH, Richardson D et al. Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in nonsmall-cell lung cancer. J Clin Oncol 2005; 23:8959–8967.PubMedGoogle Scholar
  238. 238.
    Tomita M, Matsuzaki Y, Edagawa M et al. Distribution of Mast Cells in Mediastinal Lymph Nodes from Lung Cancer Patients. World J Surg Oncol 2003; 1:25.PubMedGoogle Scholar
  239. 239.
    Kawai O, Ishii G, Kubota K et al. Predominant infiltration of macrophages and CD8(+) T-Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Cancer 2008;113:1387–1395.PubMedGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2011

Authors and Affiliations

  • Elena P. Moiseeva
    • 1
  • Peter Bradding
    • 1
    • 2
  1. 1.Department of Infection, Immunity and Inflammation, Institute for Lung HealthUniversity of LeicesterLeicesterUK
  2. 2.Department of Respiratory MedicineGlenfield HospitalLeicesterUK

Personalised recommendations